Precision Medicine

Precision Medicine

U.S. FDA Approves TREMFYA® (Guselkumab) for Pediatric Plaque Psoriasis and Active Psoriatic Arthritis — First IL-23 Inhibitor Cleared for Children

U.S. FDA Approves TREMFYA® (Guselkumab) for Pediatric Plaque Psoriasis and Active Psoriatic Arthritis — First IL-23 Inhibitor Cleared for Children

29 Sep 2025

2 min read

Apollo Health

ReCODE Protocol Shows Promise in Reducing Depression Among Patients with Cognitive Impairment

27 Sep 2025

2 min read

Pertizumab

Hetero Healthcare and Enzene Biosciences Launch Affordable Biosimilar Pertuzumab ‘Perzea’ for Breast Cancer Patients in India

26 Sep 2025

1 min read

Boehringer Ingelheim

TegMine Therapeutics and Boehringer Ingelheim Partner to Develop Next-Generation Cancer Therapies

25 Sep 2025

1 min read

Guardant Health

Guardant Health and Quest Diagnostics Partner to Expand Access to FDA-Approved Blood Test for Colorectal Cancer Screening

25 Sep 2025

2 min read

FDA Grants Priority Review to ENHERTU® Plus Pertuzumab for First-Line HER2 Positive Metastatic Breast Cancer

FDA Grants Priority Review to ENHERTU® Plus Pertuzumab for First-Line HER2 Positive Metastatic Breast Cancer

25 Sep 2025

2 min read

Read More

Voice Of HealthCare

vohnetwork.com